WP
Waycross Partners Portfolio holdings
AUM
$1.06B
This Quarter Return
+10.35%
1 Year Return
+18.76%
3 Year Return
+112.27%
5 Year Return
–
10 Year Return
–
AUM
$188M
AUM Growth
+$188M
(+4.9%)
Cap. Flow
-$7.17M
Cap. Flow
% of AUM
-3.81%
Top 10 Holdings %
Top 10 Hldgs %
39.03%
Holding
92
New
–
Increased
16
Reduced
25
Closed
11
Top Buys
| 1 |
AbbVie
ABBV
|
$3.11M |
| 2 |
Citigroup
C
|
$1.19M |
| 3 |
Autodesk
ADSK
|
$613K |
| 4 |
Intuit
INTU
|
$613K |
| 5 |
Visa
V
|
$514K |
Top Sells
| 1 |
Pultegroup
PHM
|
$3.05M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
$1.54M |
| 3 |
GE Aerospace
GE
|
$1.26M |
| 4 |
Hewlett Packard
HPE
|
$1.23M |
| 5 |
WRK
WestRock Company
WRK
|
$1.17M |
Sector Composition
| 1 | Technology | 22.51% |
| 2 | Financials | 20.21% |
| 3 | Healthcare | 18.37% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
NetApp
NTAP
$22.6B
| $1.07M | 0.57% | 13,100 | – | – |
|
52
Papa John's
PZZA
$1.6B
| $1.04M | 0.55% | 10,000 | – | – |
|
53
CVS Health
CVS
$92.8B
| $1.04M | 0.55% | 12,400 | – | – |
|
|
54
Autodesk
ADSK
$67.3B
| $1.02M | 0.54% | 3,500 +2,100 | +150% | +$613K |
|
55
Gilead Sciences
GILD
$140B
| $964K | 0.51% | 14,000 | – | – |
|
|
ATVI
56
DELISTED
Activision Blizzard Inc.
ATVI
| $954K | 0.51% | 10,000 | – | – |
|
57
Fluor
FLR
$6.63B
| $888K | 0.47% | 50,168 -2,309 | -4% | -$40.9K |
|
|
PXD
58
DELISTED
Pioneer Natural Resource Co.
PXD
| $813K | 0.43% | 5,000 -9,500 | -66% | -$1.54M |
|
59
Abbott
ABT
$231B
| $729K | 0.39% | 6,289 | – | – |
|
60
Nike
NKE
$114B
| $726K | 0.39% | 4,700 | – | – |
|
61
Fiserv
FI
$75.1B
| $695K | 0.37% | 6,500 | – | – |
|
62
PepsiCo
PEP
$204B
| $657K | 0.35% | 4,433 | – | – |
|
63
Vertex Pharmaceuticals
VRTX
$100B
| $595K | 0.32% | 2,951 | – | – |
|
64
Procter & Gamble
PG
$368B
| $581K | 0.31% | 4,309 | – | – |
|
65
Lockheed Martin
LMT
$106B
| $549K | 0.29% | 1,450 | – | – |
|
66
Starbucks
SBUX
$100B
| $503K | 0.27% | 4,500 +1,725 | +62% | +$193K |
|
67
Pfizer
PFE
$141B
| $499K | 0.27% | 12,745 | – | – |
|
68
Colgate-Palmolive
CL
$67.9B
| $488K | 0.26% | 6,000 | – | – |
|
69
DexCom
DXCM
$29.5B
| $470K | 0.25% | 1,100 | – | – |
|
70
Norwegian Cruise Line
NCLH
$11.2B
| $441K | 0.23% | 15,000 | – | – |
|
71
BioMarin Pharmaceuticals
BMRN
$11.2B
| $384K | 0.2% | 4,600 | – | – |
|
72
Bristol-Myers Squibb
BMY
$96B
| $304K | 0.16% | 4,557 | – | – |
|
73
Johnson & Johnson
JNJ
$427B
| $280K | 0.15% | 1,700 | – | – |
|
|
SAGE
74
DELISTED
Sage Therapeutics
SAGE
| $210K | 0.11% | 3,700 | – | – |
|
75
Philip Morris
PM
$260B
| $160K | 0.09% | 1,619 | – | – |
|